First Eagle Investment Management, LLCFirst Eagle Investment Management, LLC

Institutional investor · Portfolio as of Q4 2024

SEC EDGAR SourceSEC Filings

Top Holdings423 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

META PLATFORMS INC-CLASS A

3.5M$2.1B4.6%$174.29+238.17%
25 qtrssince 2018-Q4
Decreased
0

ORACLE CORP

12.3M$2B4.6%$40.60+306.02%
25 qtrssince 2018-Q4
Decreased
0

WILLIS TOWERS WATSON PLC

4.5M$1.4B3.1%$188.52+63.85%
25 qtrssince 2018-Q4
Decreased
0

HCA HOLDINGS INC

4.5M$1.4B3.0%$150.76+96.47%
25 qtrssince 2018-Q4
Increased
59

IMPERIAL OIL LTD

21.2M$1.3B2.9%$20.85+185.61%
25 qtrssince 2018-Q4
Decreased
0

COMCAST CORP-CLASS A

34.1M$1.3B2.9%$27.35+22.06%
25 qtrssince 2018-Q4
Increased
59

ALPHABET INC-CL C

6.7M$1.3B2.8%$96.31+99.30%
25 qtrssince 2018-Q4
Decreased
0

ANTHEM INC

3.2M$1.2B2.7%$320.50+12.89%
25 qtrssince 2018-Q4
Increased
75

PHILIP MORRIS INTERNATIONAL

9.5M$1.1B2.6%$54.79+111.53%
25 qtrssince 2018-Q4
Decreased
0
TSMTSM
ADR

TAIWAN SEMICONDUCTOR SPONSORED ADR /1 ADR REPS 5 ORD SHS/

5.6M$1.1B2.5%$33.83+484.51%
25 qtrssince 2018-Q4
Decreased
0

C.H. ROBINSON WORLDWIDE INC

10.7M$1.1B2.5%$69.39+44.72%
25 qtrssince 2018-Q4
Decreased
0
FMXFMX
Unit

FOMENTO ECONOMICO MEXICANO SAB /1 ADR REPRS 10 UT CONS 10 SERB &20 SER D-B SHS &20 SER D-L/

12.7M$1.1B2.4%$61.32+28.99%
20 qtrssince 2020-Q1
Increased
65

BANK OF NEW YORK MELLON CORP

14M$1.1B2.4%$38.06+97.35%
25 qtrssince 2018-Q4
Decreased
0

WHEATON PRECIOUS METALS CORP

19M$1.1B2.4%$22.54+147.76%
25 qtrssince 2018-Q4
Decreased
0

SCHLUMBERGER LTD

27.8M$1.1B2.4%$29.21+24.70%
25 qtrssince 2018-Q4
Increased
55

BECTON DICKINSON AND CO

4.4M$1B2.2%$175.19-1.68%
17 qtrssince 2020-Q4
Increased
70

EXXON MOBIL CORP

8.7M$933.9M2.1%$43.60+132.45%
25 qtrssince 2018-Q4
Decreased
0

UNIVERSAL HEALTH SERVICES-B

4.7M$838.8M1.9%$118.39+50.04%
25 qtrssince 2018-Q4
Increased
50

COLGATE-PALMOLIVE CO

8.7M$792.7M1.8%$50.33+73.21%
25 qtrssince 2018-Q4
Decreased
0

SALESFORCE.COM INC

2.4M$787.4M1.8%$207.54+60.72%
19 qtrssince 2020-Q2
Decreased
0
$44.8B
AUM
423
Positions
Q4 2024
Filing
Rating · 3.5
Quarterly Portfolio Change
-1%Q3'23$38.7B+9%Q4'23$42B+5%Q1'24$44B+1%Q2'24$44.7B+9%Q3'24$48.6B-8%Q4'24$44.8B
Activity profile
$ moved · Q4'24
New9%Increased28%Decreased63%Exited1%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 2.6 years
<1Q9%1-4Q13%1-2Y16%2Y+62%

First Eagle Investment Management, LLC manages $44.8B across 423 positions as of Q4 2024. Top holdings: META (4.6%), ORCL (4.6%), WTW (3.1%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 3.5/5.0.

Q4 2024 Summary

Active quarter - 47 new positions, 18 exits, 206 increased. Top move: ELV (INCREASED, conviction 75). Portfolio: $44.8B across 423 positions.

Top holdings by portfolio weight

Total AUM$45B
META4.63%
ORCL4.57%
WTW3.12%
HCA3.02%
IMO2.91%
CMCSA2.86%
GOOG2.84%
ELV2.66%
PM2.55%
TSM2.49%
Other2.48%

Portfolio allocation by GICS sector

Sectors11
Technology13.84%
Healthcare13.27%
Communication Services13.02%
Financial Services11.86%
Energy10.65%
Basic Materials10.40%
Consumer Defensive7.82%
Industrials7.20%
Real Estate5.91%
Unknown4.89%
Other1.14%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Technology, Healthcare, Communication Services
Compare DNA across all funds
7-dimension quality assessment
Strong(3.5 / 5.0)
Track Record77
Conviction41
Concentration44
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
8Q
BDXBDXBECTON DICKINSON AND CO
Q3 2024 Q2 2026+11M shares+$1.4B
8Q
BIOBIOBIO-RAD LABORATORIES-A
Q3 2024 Q2 2026+2M shares+$591.4M
8Q
BTIBTIBRITISH AMERICAN TOB-SP ADR
Q3 2024 Q2 2026+939,374 shares+$82M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used